Drug
AV 380
AV 380: highest development phase Phase 1, developed by Aveo Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Aveo Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| AV-380 NCT04815551 | Phase 1 | Cachexia |
| AV-380 NCT05865535 | Phase 1 | Cachexia |
Latest
Follow AV 380 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.